Home > Events > Conference > EQA 2026 – Rare Neuromuscular Diseases
A A A

EQA 2026 – Rare Neuromuscular Diseases

06 Mar – 06 Feb 2026

Italy

Hybrid

We are pleased to announce a scientific workshop dedicated to the role of External Quality Assessment (EQA) in the correct interpretation of muscle biopsy.

📅 March 6, 2026 | 10:00 AM – 4:00 PM 📍 Mangiagalli Auditorium, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan | Hybrid event

This meeting will bring together leading experts to discuss key topics including: → Structure and management of EQA programs: the Italian Lombardy Region experience → Indications for muscle biopsy in the post-genomic era → Ultrastructural investigations and peripheral nerve histopathology → Biopsy as an outcome measure in therapeutic trials → Pathogenesis of muscular dystrophies, metabolic myopathies, and inflammatory myopathies → Spatial multi-omics technologies in neuromuscular disease research → From diagnosis to therapy: current perspectives

With the patronage of the European Reference Network (ERN) and featuring a session on ERN Neuropathology Group activities.

🎯 An essential update for neurologists, pathologists, and researchers working in the neuromuscular field.

📩 Info & registration: malattieneuromuscolari@policlinico.mi.it

#Neurology #RareDiseases #NeuromuscularDiseases #MuscleBiopsy #EQA #Myopathies #PrecisionMedicine #MedicalEducation #CME